Global Ranitidine Market, By Indication (Intestinal & Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, and Others), Population Type (Children and Adults), Dosage Form (Solid Oral, Liquid, and Parenteral), Dosage Strength (Oral Strength and Parenteral Strength), Mode of Purchase (Over The Counter and prescription), End User (Hospitals, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, online Pharmacies and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Ranitidine Market
Ranitidine market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to growing at a CAGR of 2.60% and is expected to reach USD 502.4 million till 2028, in the above-mentioned forecast period. Increasing in acidity/heartburn problems and changing food habits and increase gluten intake will assist in encouraging the growth of the market.
An increase in gastroesophageal reflux disease complications and acid reflux by drinks, foods, and other medication will lead to a boost in market growth. Rising disposable income of consumers in emerging economies along with an increasing prescription for ranitidine will additionally heighten numerous opportunities that will commence to the germination of the ranitidine market in the above-mentioned forecast period. The increase in the alternative in the market and side-effect of ranitidine restraint the ranitidine market.
This ranitidine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research ranitidine market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Ranitidine Market Scope and Market Size
Ranitidine market is segmented on the basis of indication, population type, dosage form, dosage strength, mode of purchase, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of indication, the ranitidine market is segmented into intestinal & stomach ulcers, gastroesophageal reflux disease (GERD), esophagitis, zollinger-ellison syndrome, and others.
- On the basis of population type, the ranitidine market is segmented into children and adults.
- On the basis of dosage form, the ranitidine market is segmented into solid oral, liquid and parenteral.
- On the basis of dosage strength, the ranitidine market is segmented into oral strength and parenteral strength. Oral strength is further segmented into 75 mg, 150 mg, 300 mg.
- On the basis of mode of purchase, the ranitidine market is segmented into over the counter and prescription.
- On the basis of end user, the ranitidine market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the ranitidine market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.
Ranitidine Market Country Level Analysis
Ranitidine market is analysed and market size insights and trends are provided by indication, population type, dosage form, dosage strength, mode of purchase, end user and distribution channel as referenced above.
The countries covered in the ranitidine market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America governs the ranitidine market industry owing to increase in ranitidine drug prescriptions and prevalence of gastrointestinal diseases while Asia-Pacific is anticipated to expand at the most leading germination pace in the estimated duration of 2021 to 2028 due to the increase in healthcare expenditure and rising disposable income.
The country section of the ranitidine market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Ranitidine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Ranitidine Market Share Analysis
Ranitidine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ranitidine market.
The major players operating in the ranitidine market report are Sanofi, GENPHARM, Sandoz International GmbH, Teva Pharmaceuticals USA Inc, GlaxoSmithKline plc, Mylan N.V., Par Pharmaceutical, Perrigo Company plc, Sun Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, LLC., Strides Pharma Science Limited, Dr. Reddy’s Laboratories Ltd., Laboratoire Riva., Pharmascience Inc. and Vita Health Products Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.